Neuropediatrics 2005; 36(6): 380-385
DOI: 10.1055/s-2005-873078
Original Article

Georg Thieme Verlag KG Stuttgart · New York

Cerebrospinal Fluid Concentrations of Folate, Biogenic Amines and Pterins in Rett Syndrome: Treatment with Folinic Acid

A. Ormazabal1 , R. Artuch1 , M. A. Vilaseca1 , A. Aracil2 , M. Pineda2
  • 1Department of Clinical Chemistry, Hospital Sant Joan de Déu, Barcelona, Spain
  • 2Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain
Further Information

Publication History

Received: August 5, 2005

Accepted after Revision: December 5, 2005

Publication Date:
23 January 2006 (online)

Preview

Abstract

Background: Previous studies in Rett syndrome (RS) patients suggested various abnormalities in biogenic amines, pterins, and folate values in cerebrospinal fluid (CSF). Our aim was to analyse these metabolites in CSF of 16 RS patients (age range: 2 - 23 years). Biogenic amines, pterins, and 5-methyltetrahydrofolate were measured by HPLC with electrochemical and fluorescence detection. Results: CSF values of 5-methyltetrahydrofolate were decreased in 8 out of 16 RS patients (average: 53.6 nmol/L; range: 19 - 92) when compared with our reference values (average: 74.6 nmol/L; range: 45 - 127). These eight patients had epilepsy, while 4 out of 16 RS patients who did not have epilepsy showed normal CSF 5-methyltetrahydrofolate concentrations. Values of biogenic amines or pterins were decreased in four of the patients with low values of 5-methyltetrahydrofolate. No correlation was observed between CSF values of 5-methyltetrahydrofolate and pterins, biogenic amines, or age. Supplementation with folinic acid was applied in six out of the eight patients with CSF 5-methyltetrahydrofolate deficiency. An improvement was noticed in all cases. Conclusions: An important percentage of RS patients showed 5-methyltetrahydrofolate concentrations under the reference values. Therefore, analysis of CSF 5-methyltetrahydrofolate seems advisable in RS, especially in patients with epilepsy and those resistant to antiepileptic drugs.

References

Rafael Artuch

Clinical Chemistry Department
Hospital Sant Joan de Déu

Passeig Sant Joan de Déu, 2

08950 Esplugues de Llobregat (Barcelona)

Spain

Email: rartuch@hsjdbcn.org